PCA
MRNA icon

Private Capital Advisors’s Moderna MRNA Stock Holding History

Private Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,700
Closed -$207K – 94
2023
Q2 		$207K Buy
+1,700
New +$227K 0.03% 75
2021
Q1 		– Sell
-2,885
Closed -$301K – 106
2020
Q4 		$301K Buy
+2,885
New +$292K 0.06% 76

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Private Capital Advisors's MRNA Position: Q3 2023 in Review

Private Capital Advisors sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,700 shares — an estimated $207K sold.

Private Capital Advisors first reported a position in MRNA in Q4 2020 and held it in 2 quarters. The position peaked at $301K in Q4 2020. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Private Capital Advisors reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Private Capital Advisors sold 1,700 Moderna shares in Q3 2023, an estimated $207K.
  • Private Capital Advisors first reported a position in Moderna in Q4 2020 and held it in 2 quarters.
  • Private Capital Advisors's Moderna position peaked at $301K in Q4 2020.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Private Capital Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.